Krystal Biotech, Inc. (KRYS)
309.03
-1.27
(-0.41%)
USD |
NASDAQ |
May 29, 16:00
317.00
+7.97
(+2.58%)
After-Hours: 20:00
Krystal Biotech Total Liabilities (Quarterly) : 120.24M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 3.638M |
| Tenaya Therapeutics, Inc. | 28.88M |
| TG Therapeutics, Inc. | 945.71M |
| Vericel Corp. | 129.40M |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.397B |
| Shareholders Equity (Quarterly) | 1.277B |
| Debt to Equity Ratio | 0.0071 |
| Current Ratio | 9.459 |
| Net Debt Paydown Yield | -0.00% |